About
Luminera Derm is an R&D company and manufacturer of injectable medical devices in the field of aesthetic medicine. Crystalys is a calcium hydroxyapatite-based injectable dermal filler designed to restore facial volume and natural contours by promoting generation and deposition of natural collagen, the body's physiological soft-tissue filler. HArmonyCa is designed to restore facial volume and correct facial deficiencies by promoting the generation of natural endogenous collagen. Hydryalix is a sterile, transparent, cross-linked hyaluronic acid injectable filler. Hydryal is an injectable, non-cross-linked hyaluronic acid clear gel, designed to enhance skin hydration and restore skin vitality. All Luminera products strictly comply with ISO9001 and ISO13485 standards.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Luminera Derm acquired and by which company?
- Luminera Derm was acquired by Allergan Aesthetics in October 2020.
- What is Luminera Derm's primary business activity?
- Luminera Derm is an R&D company and manufacturer of injectable medical devices for aesthetic medicine.
- What type of product is Crystalys?
- Crystalys is a calcium hydroxyapatite-based injectable dermal filler designed to restore facial volume and promote natural collagen generation.
- What is the purpose of HArmonyCa?
- HArmonyCa is designed to restore facial volume and correct facial deficiencies by promoting the generation of natural endogenous collagen.
- What are the characteristics of Hydryalix?
- Hydryalix is a sterile, transparent, cross-linked hyaluronic acid injectable filler.
- What is Hydryal designed for?
- Hydryal is an injectable, non-cross-linked hyaluronic acid clear gel, designed to enhance skin hydration and restore skin vitality.
- Where is Luminera Derm headquartered?
- Luminera Derm is headquartered in Lod, Israel.
- In which geographic markets did Luminera Derm operate?
- Luminera Derm operated in geographic markets including Azerbaijan, Kazakhstan, Israel, Turkey, Europe, Japan, and Cyprus.